Muscarinic M1, M3, Nicotinic,GABAA and GABAB Receptor ...

Steriade M. (1996). Arousal: revisiting the reticular activating system. Science, 272:
225–226.
Stillman MJ, Shukitt–Hale B, Galli RL, Levy A, Lieberman HR. (1996). Effects of
M2 antagonists on in vivo hippocampal acetylcholine levels. Brain Res Bull, 41:
221–226.
Straessle A, Loup F, Arabadzisz D, Ohning GV, Fritschy JM. (2003). Rapid and long–
term alterations of hippocampal GABAB receptors in a mouse model of temporal
lobe epilepsy. Eur J Neurosci, 18: 2213–2226.
Strubbe JH, Steffens AB. (1993). Neural control of insulin secretion. Horm. Metab.
Res., 25: 507–12.
Suda S, Shinohara M, Miyaoka M, Lucignani G, Kennedy C, Sokoloff L. (1990). The
lumped constant of the deoxyglucose method in hypoglycemia: effects of
moderate hypoglycemia on local cerebral glucose utilization in the rat. J Cereb
Blood Flow Metab, 10: 499–509.
Sugita S, Uchimura N, Jiang ZG, North RA. (1991). Distinct muscarinic receptors
inhibit release of g–aminobutyric acid and excitatory amino acids in mammalian
brain. Proc Natn Acad Sci. USA, 88: 2608–2611.
Suh SW, Aoyama K, Chen Y, Garnier P, Matsumori Y, Gum E, Liu J, Swanson RA.
(2003). Hypoglycemic neuronal death and cognitive impairment are prevented by
poly(ADP–ribose) polymerase inhibitors administered after hypoglycemia. J
Neurosci, 23: 10681–10690.